Skip to main content
Clinical Trials/CTRI/2024/07/071082
CTRI/2024/07/071082
Not yet recruiting
Phase 4

A Randomised controlled study comparing Hyperbaric Levobupivacaine 0.5 percent with Hyperbaric Bupivacaine 0.5 percent for its efficacy in Spinal Anaesthesia for lower abdominal and lower limb surgeries

D Y Patil Hospital1 site in 1 country60 target enrollmentStarted: August 5, 2024Last updated:

Overview

Phase
Phase 4
Status
Not yet recruiting
Enrollment
60
Locations
1
Primary Endpoint
To compare the clinical efficacy of hyperbaric bupivacaine 0.5% and hyperbaric levobupivacaine 0.5% in spinal anaesthesia based on onset of motor block

Overview

Brief Summary

60 patients of ASA class I or class II of either sex, between 18-65 years undergoing elective lower abdominal and lower limb surgeries and who gave written informed consent for the study, will be recruited and randomized .After clinical assessment and routine investigations , they will randomly be allocated into two groups containing 30 patients each.

Group A will receive spinal anaesthesia using 3.2 ml of 0.5% bupivacaine heavy.

Group B will receive spinal anaesthesia using 3.2 ml of 0.5% Levobupivacaine heavy.

After taking the patient inside the operation theatre, the monitors will be placed and continuous monitoring will be done. After the injection of the spinal medication, heart rate and arterial blood pressure will be measured. Arterial pressure and heart rate will be recorded at 2min interval upto 20min and 10min intervals thereafter until 60 mins  followed by 30mins till 180mins.

The assessments of sensory block done by pinprick test and Results of the pin rick test were determined bilaterally at midclavicular level by needle. Motor block in the lower limb was assessed by using a modified Bromage scale (0 no paralysis, 1 unable to raise extended leg, 2 unable to flex knee, 3 unable to flex ankle).

These assessments will be performed immediately after the assessments of sensory block until the return of normal motor function. The measurement will also include peak block height, motor and sensory blockade, duration and side effects.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • 1.Patient undergoing abdominal and lower limb surgeries under spinal anaesthesia 2.ASA 1 and 2.

Exclusion Criteria

  • 1.Known hypersensitivity to amide local anaesthetics 2.Contraindications for spinal anaesthesia 3.Bleeding disorders or on anti-coagulant therapy , documented neuromuscular therapy 4.Any infection at the injection site 5.Any spinal deformity 6.Pregnant patients.

Outcomes

Primary Outcomes

To compare the clinical efficacy of hyperbaric bupivacaine 0.5% and hyperbaric levobupivacaine 0.5% in spinal anaesthesia based on onset of motor block

Time Frame: every 2 mins for first 20mins followed by every 10mins till 60mins then every 30mins till 180mins

Secondary Outcomes

  • Time taken for complete motor blockade , onset of sensory blockade, duration of sensory and motor blockade and hemodynamic parameters(every 2 mins for first 20mins followed by every 10mins till 60mins then every 30mins till 180mins)

Investigators

Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Noopur Choudhary

D Y Patil Hospital

Study Sites (1)

Loading locations...

Similar Trials